Viridian Therapeutics, Inc. planned insider sales
In the last twelve months insiders at Viridian Therapeutics, Inc. filed 6 Form 144 notices of planned sales, 30,646 shares worth $846,470 at the time of filing, from 4 sellers. The latest, filed 19 August 2026: Tousignant Jennifer (officer), 14,212 shares worth $348,194, planned for around 19 August 2026 through Fidelity Brokerage Services LLC.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 19 August 2026 | Tousignant Jennifer | Officer | 14,212 | $348,194 | 19 August 2026 | 14,212 shares from 19 August 2026 | Fidelity Brokerage Services LLC | ESPP Purchase; Restricted Stock Vesting; Stock Option Exercise | Form 144 |
| 4 March 2026 | Tousignant Jennifer | Officer | 1,675 | $50,560 | 4 March 2026 | No matching Form 4 sale | Fidelity Brokerage Services LLC | Restricted Stock Vesting | Form 144 |
| 4 March 2026 | Harmon Seth | Officer | 2,031 | $61,306 | 4 March 2026 | No matching Form 4 sale | Fidelity Brokerage Services LLC | Restricted Stock Vesting | Form 144 |
| 4 March 2026 | Beetham Thomas W. | Officer | 3,048 | $92,004 | 4 March 2026 | No matching Form 4 sale | Fidelity Brokerage Services LLC | Restricted Stock Vesting | Form 144 |
| 4 March 2026 | Mahoney Stephen F. | Officer, Director | 7,408 | $223,610 | 4 March 2026 | No matching Form 4 sale | Fidelity Brokerage Services LLC | Restricted Stock Vesting | Form 144 |
| 31 December 2025 | Tousignant Jennifer | Officer | 2,272 | $70,796 | 31 December 2025 | 2,272 shares from 31 December 2025 | Fidelity Brokerage Services LLC | ESPP Purchase | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.